STAT+ Conversations
Pop-up virtual events featuring our reporters and leading industry experts. They’ll take the opportunity to dive deep into the story of the moment. Check out the registration page to see what’s next.
Most Read
STAT Plus: STAT+ Conversation: Selling Cellarity
STAT Plus: STAT+ Conversation: What’s next in gene therapy
STAT Plus: STAT+ Conversation: Which biotech venture capital funds performed best during the pandemic?
STAT Plus: STAT+ Conversation: Theranos returns
STAT Plus: STAT+ Conversation: Dealing with the Delta variant
STAT Plus: STAT+ Conversations: A conversation on scrutiny facing Epic’s health care algorithms
STAT Plus: STAT+ Conversations: A conversation about in vivo gene editing to treat rare disease
All Coverage
advertisement